{"content":"<li class=\"n-box-item date-title\" data-end=\"1497412799\" data-start=\"1497326400\" data-txt=\"Monday, December 23, 2019\">Tuesday, June 13, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3273320\" data-ts=\"1497395761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273320-h-and-r-blockplus-10-following-strong-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;R Block +10% following strong earnings beat</a></h4><ul>     <li>H&amp;R&nbsp;Block (NYSE:<a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a>)&nbsp;<font color='green'>+10.1%</font>&nbsp;AH after routing <a href=\"https://seekingalpha.com/news/3273288-h-and-amp-r-block-beats-0_23-beats-revenue\" target=\"_blank\">FQ4 earnings</a> expectations even as revenues came in flat, and <a href=\"https://seekingalpha.com/news/3273290-h-and-r-block-declares-0_24-dividend\" target=\"_blank\">raising its quarterly dividend by 9%</a> to $0.24/share.</li>     <li>HRB says its net income from continuing operations jumped 10% Y/Y to $421M, EBITDA from continuing operations rose 11% to $904M, and EBITDA margin was  29.8%, up more than 300 bps from a year ago.</li>     <li>Total operating expenses fell 3.5% Y/Y to $85M, and results are were helped from having lower bad debt expense from more favorable collections on prior year receivables.</li>     <li>&ldquo;We wanted to be very aggressive on our marketing and promotions. We knew we had to arrest the client decline in our assisted business and grow share in the digital business, and we were able to accomplish both of those goals,\" CEO&nbsp;Bill Cobb <a href=\"http://www.bizjournals.com/kansascity/news/2017/06/13/hr-block-fiscal-year-earnings-bill-cobb.html\" target=\"_blank\">says</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273320\" data-linked=\"H&amp;R Block +10% following strong earnings beat\" data-tweet=\"$HRB - H&amp;R Block +10% following strong earnings beat https://seekingalpha.com/news/3273320-h-and-r-blockplus-10-following-strong-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3273320-h-and-r-blockplus-10-following-strong-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273314\" data-ts=\"1497391769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273314-nba-finals-lead-abc-to-prime-time-ratings-win\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NBA Finals lead ABC to prime-time ratings win</a></h4><ul>   <li>Once again, basketball made the difference in prime-time ratings, with ABC (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.5%</font>) <a href=\"http://www.statesman.com/news/viewership-down-abc-the-bachelorette-other-reality/0JNcV8lOSTGbXJEA5Y0RUI/\" target=\"_blank\">taking the week's ratings lead</a> thanks to the NBA Finals.</li>    <li>The network averaged 6.8M viewers, well ahead of NBC (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.6%</font>) at 5.5M, with two broadcasts of the championship series games between the Golden State Warriors and Cleveland Cavaliers. Game 3 and Game 4 of the series were the most-watched individual programs of the week, with 20.1M and 19.01M viewers respectively.</li>    <li>Behind NBC, CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-1.3%</font>) drew 4.8M viewers in prime time, and Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-1.8%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-2.4%</font>) average 2.1M, ahead of Univision's 1.7M.</li>    <li>On cable nets, Fox News led gain with 2.33M viewers, ahead of MSNBC's 1.81M; USA Network with 1.44M; HGTV (<a href=\"http://seekingalpha.com/symbol/SNI\" target=\"_blank\">SNI</a> <font color='red'>-1.4%</font>) with 1.39M; and TBS (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='red'>-0.8%</font>) with 1.34M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273314\" data-linked=\"NBA Finals lead ABC to prime-time ratings win\" data-tweet=\"$FOX $FOX $FOXA - NBA Finals lead ABC to prime-time ratings win https://seekingalpha.com/news/3273314-nba-finals-lead-abc-to-prime-time-ratings-win?source=tweet\" data-url=\"https://seekingalpha.com/news/3273314-nba-finals-lead-abc-to-prime-time-ratings-win\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273311\" data-ts=\"1497389778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273311-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a> <font color='green'>+10.4%</font>. <a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/NVDQ' title='Novadaq Technologies Inc.'>NVDQ</a> <font color='green'>+1.4%</font>. <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='green'>+1.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color='red'>-5.4%</font>. <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/PDLI' title='PDL BioPharma, Inc.'>PDLI</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273311\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$HRB $ALXN $IPI - After Hours Gainers / Losers https://seekingalpha.com/news/3273311-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273311-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273303\" data-ts=\"1497387388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRX\" target=\"_blank\">AMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273303-impax-on-deck-for-presentation-gs-healthcare-conference-shares-ease-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impax on deck for presentation at GS Healthcare Conference; shares ease 3% after hours</a></h4><ul><li>Impax Laboratories (IPXL) slips&nbsp;<font color='red'>3%</font>&nbsp;after hours on average volume ahead of today's <a href=\"https://seekingalpha.com/pr/16856867-impax-present-goldman-sachs-38th-annual-global-healthcare-conference\" target=\"_blank\">presentation </a>at the Goldman Sachs Global Healthcare Conference. The show is set to begin in less than an hour.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273303\" data-linked=\"Impax on deck for presentation at GS Healthcare Conference; shares ease 3% after hours\" data-tweet=\"$AMRX - Impax on deck for presentation at GS Healthcare Conference; shares ease 3% after hours https://seekingalpha.com/news/3273303-impax-on-deck-for-presentation-gs-healthcare-conference-shares-ease-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3273303-impax-on-deck-for-presentation-gs-healthcare-conference-shares-ease-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273301\" data-ts=\"1497387055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZDGE\" target=\"_blank\">ZDGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273301-zedge-swings-to-loss-sets-new-growth-initiatives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zedge swings to loss as it sets new growth initiatives</a></h4><ul>   <li>Zedge (<a href=\"http://seekingalpha.com/symbol/ZDGE\" target=\"_blank\">ZDGE</a> <font color='green'>+3.4%</font>) swung to a loss in <a href=\"https://seekingalpha.com/news/3273292-zedge-reports-q3-results\" target=\"_blank\">fiscal Q3 earnings</a> as revenues fell slightly from the prior year.</li>    <li>The company posted a loss from operations of $193,000, vs. year-ago operating income of $243,000.</li>    <li>Monthly active users for the past 30 days were up 0.3% to 31.7M -- down 5.1% sequentially. Total installs were up 28.5% to 260.4M vs. the prior year.</li>    <li>Average revenue per MAU from apps rose 0.8% Y/Y and 5.1% Q/Q to $0.0249.</li>    <li>Working capital was up to $5.3M from a year-ago $3.9M.</li>    <li>&ldquo;In summarizing the quarter I would highlight our doubling down on projects that we expect to put us back on a growth trajectory especially across higher value geographies, and executing with excellence on a highly focused set of user and content-centric initiatives,\" says CEO and co-founder Tom Arnoy.</li>    <li><a href=\"http://services.choruscall.com/links/zdge170613C8rjqToL.html\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16860986-zedge-announces-third-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3273301\" data-linked=\"Zedge swings to loss as it sets new growth initiatives\" data-tweet=\"$ZDGE - Zedge swings to loss as it sets new growth initiatives https://seekingalpha.com/news/3273301-zedge-swings-to-loss-sets-new-growth-initiatives?source=tweet\" data-url=\"https://seekingalpha.com/news/3273301-zedge-swings-to-loss-sets-new-growth-initiatives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273297\" data-ts=\"1497386114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQNS\" target=\"_blank\">SQNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273297-sequans-announces-american-depositary-shares-offering-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sequans announces American Depositary Shares offering; shares down 6%</a></h4><ul><li>        Sequans Communications (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a>) <a href=\"https://seekingalpha.com/pr/16860955-sequans-communications-s-announces-proposed-underwritten-public-offering-american-depositary\" target=\"_blank\">offers</a> newly issued ADSs representing ordinary shares with the final terms dependent on market conditions. The company will use proceeds for general corporate purposes.</li><li>               Sequans provides 4G LTE wireless semiconductors for broadband data devices and &ldquo;Internet of Things&rdquo; devices.&nbsp;</li><li>               Sequans shares are&nbsp;<font color='red'>down nearly 6%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3273297\" data-linked=\"Sequans announces American Depositary Shares offering; shares down 6%\" data-tweet=\"$SQNS - Sequans announces American Depositary Shares offering; shares down 6% https://seekingalpha.com/news/3273297-sequans-announces-american-depositary-shares-offering-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3273297-sequans-announces-american-depositary-shares-offering-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273296\" data-ts=\"1497386101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273296-biogen-finance-chief-cuts-cord-for-greener-pastures-alexion-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen finance chief cuts cord for greener pastures at Alexion; shares down 2% after hours</a></h4><ul><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) is down&nbsp;<font color='red'>2%</font>&nbsp;after hours on average volume after it <a href=\"https://seekingalpha.com/filing/3592552\" target=\"_blank\">announced</a> that CFO Paul Clancy will resign at the end of June to take a position at another biopharmaceutical company.</li><li>VP, Finance and Chief Accounting Officer Gregory Covino will take over on an interim basis as Principal Financial Officer until a new CFO is hired.</li><li><strong>Update</strong>: Mr. Clancy will join Alexion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>) as CFO. Stock is up&nbsp;<font color='green'>3%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273296\" data-linked=\"Biogen finance chief cuts cord for greener pastures at Alexion; shares down 2% after hours\" data-tweet=\"$BIIB $BIIB $ALXN - Biogen finance chief cuts cord for greener pastures at Alexion; shares down 2% after hours https://seekingalpha.com/news/3273296-biogen-finance-chief-cuts-cord-for-greener-pastures-alexion-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3273296-biogen-finance-chief-cuts-cord-for-greener-pastures-alexion-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273288\" data-ts=\"1497385136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRB\" target=\"_blank\">HRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273288-handr-block-beats-0_23-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H&amp;amp;R Block beats by $0.23, beats on revenue</a></h4><ul><li>H&amp;R Block (NYSE:<a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a>): Q4 EPS of $3.76 <font color='green'>beats by $0.23</font>.</li><li>Revenue of $2.33B (+1.3% Y/Y) <font color='green'>beats by $10M</font>.</li><li>Shares <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/pr/16860978-h-and-r-block-reports-significant-earnings-margin-improvement-fiscal-2017-announces-dividend'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273288\" data-linked=\"H&amp;amp;R Block beats by $0.23, beats on revenue\" data-tweet=\"$HRB - H&amp;R Block beats by $0.23, beats on revenue https://seekingalpha.com/news/3273288-handr-block-beats-0_23-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3273288-handr-block-beats-0_23-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273285\" data-ts=\"1497384990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273285-capstone-turbine-misses-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone Turbine misses by $0.01, beats on revenue</a></h4><ul><li>Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>): Q4 EPS of -$0.13 <font color='red'>misses by $0.01</font>.</li><li>Revenue of $22.9M (+21.4% Y/Y) <font color='green'>beats by $1.4M</font>.</li><li>Shares <font color='green'>+1.25%</font>.</li><li><a href='https://seekingalpha.com/pr/16860971-capstone-turbine-reports-fourth-quarter-full-year-fiscal-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273285\" data-linked=\"Capstone Turbine misses by $0.01, beats on revenue\" data-tweet=\"$CPST - Capstone Turbine misses by $0.01, beats on revenue https://seekingalpha.com/news/3273285-capstone-turbine-misses-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3273285-capstone-turbine-misses-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273283\" data-ts=\"1497384780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOXO\" target=\"_blank\">LOXO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273283-loxo-oncology-readies-equity-offering-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loxo Oncology readies equity offering; shares down 6% after hours</a></h4><ul><li>Loxo Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/LOXO' title='Loxo Oncology'>LOXO</a>) <a href=\"https://seekingalpha.com/pr/16860930-loxo-oncology-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced. Net proceeds will fund commercialization activities for larotrectinib, R&amp;D and general corporate purposes.</li><li>Share are off&nbsp;<font color='red'>6%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273283\" data-linked=\"Loxo Oncology readies equity offering; shares down 6% after hours\" data-tweet=\"$LOXO - Loxo Oncology readies equity offering; shares down 6% after hours https://seekingalpha.com/news/3273283-loxo-oncology-readies-equity-offering-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3273283-loxo-oncology-readies-equity-offering-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273273\" data-ts=\"1497383384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEMG\" target=\"_blank\">SEMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273273-semgroup-upgraded-and-downgraded-barclays-all-on-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SemGroup upgraded and downgraded by Barclays, all on the same day</a></h4><ul><li>SemGroup (<a href='https://seekingalpha.com/symbol/SEMG' title='SemGroup Corporation'>SEMG</a> <font color='green'>+2.2%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2017-06-13/barclays-upgrades-and-downgrades-same-company-on-same-day\" target=\"_blank\">downgraded</a> to Equal      Weight from Overweight at Barclays - unremarkable, but the move comes just hours after the firm told clients that last week&rsquo;s 15%-plus drop in the stock price had left  the energy transportation company at an attractive valuation, warranting  an Overweight rating.</li><li>The abrupt about-face occurred because of a share count miscalculation, as the analysts discovered Barclays&rsquo; new  price target failed to tally ~11M shares when looking  at the total stock issued, which led to an artificially inflated  valuation.</li><li>Both notes moved the stock; the upgrade sent SEMG up by as much as  3.4%, then erased the entire gain within minutes of the second note&rsquo;s dissemination at ~11:15 a.m. in  New York, and have been moving steadily higher through the afternoon.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273273\" data-linked=\"SemGroup upgraded and downgraded by Barclays, all on the same day\" data-tweet=\"$SEMG - SemGroup upgraded and downgraded by Barclays, all on the same day https://seekingalpha.com/news/3273273-semgroup-upgraded-and-downgraded-barclays-all-on-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3273273-semgroup-upgraded-and-downgraded-barclays-all-on-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273268\" data-ts=\"1497382678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273268-bank-of-canadas-poloz-reinforces-hawkish-signal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of Canada&#39;s Poloz reinforces hawkish signal</a></h4><ul><li>Speaking <a href=\"https://www.wsj.com/articles/bocs-poloz-confident-2015-rate-cuts-have-done-their-work-1497362356?mod=e2twe\" target=\"_blank\">in a TV interview</a>, Bank of Canada Governor Stephen Poloz says 2015's rate cuts \"have done their work.\"</li><li>The economy, he says, is gathering momentum, with a growing number of sectors expanding.</li><li>His comments follow those yesterday from <a href=\"https://seekingalpha.com/news/3273201-loonie-surge-continues-investors-price-rate-hike\" target=\"_blank\">the bank's Carolyn Wilkins</a>, who suggested a rate hike could be coming far sooner than markets are expecting.</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) is&nbsp;<font color='green'>higher by 1.3%</font>&nbsp;for the day. Stocks in Toronto are modestly lower.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273268\" data-linked=\"Bank of Canada&#39;s Poloz reinforces hawkish signal\" data-tweet=\"$FXC $EWC $CNDA - Bank of Canada&#39;s Poloz reinforces hawkish signal https://seekingalpha.com/news/3273268-bank-of-canadas-poloz-reinforces-hawkish-signal?source=tweet\" data-url=\"https://seekingalpha.com/news/3273268-bank-of-canadas-poloz-reinforces-hawkish-signal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273264\" data-ts=\"1497382208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTO\" target=\"_blank\">APTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273264-aptose-continues-cg806-stoked-up-move-shares-ahead-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aptose continues CG&#39;806-stoked up move; shares ahead 11%</a></h4><ul><li>Thinly traded nano cap Aptose Biosciences (<a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a> <font color='green'>+10.9%</font>) continues its rally on more than triple normal volume. Shares have jumped almost 45% since last week when management <a href=\"https://seekingalpha.com/pr/16854446-aptose-biosciences-announces-results-annual-meeting-shareholders\" target=\"_blank\">updated </a>investors on pipeline candidates CGF'806 and APTO-253 during the Annual Meeting.</li><li>CG'806, a pan-FLT3/BTK inhibitor, showed superiority over other agents in a cellular model of FLT3-positive AML and completely eliminated AML FLT3-ITD tumors without toxicity in a mouse model. Another study reinforced CG'806's ability to kill primary malignant cells in samples from patients with a range of blood cancers.</li><li>The company is continuing its studies of APTO-253, a c-Myc oncogene inhibitor, aimed at identifying the root cause of recent manufacturing setbacks related to the intravenous formulation and to restore the molecule to an appropriate state for clinical trials and partnering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273264\" data-linked=\"Aptose continues CG&#39;806-stoked up move; shares ahead 11%\" data-tweet=\"$APTO - Aptose continues CG&#39;806-stoked up move; shares ahead 11% https://seekingalpha.com/news/3273264-aptose-continues-cg806-stoked-up-move-shares-ahead-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3273264-aptose-continues-cg806-stoked-up-move-shares-ahead-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273267\" data-ts=\"1497381759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273267-wwe-joins-liberty-in-funding-drone-racing-league\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE joins Liberty in funding Drone Racing League</a></h4><ul>   <li>The Drone Racing League has <a href=\"http://www.bizjournals.com/newyork/news/2017/06/13/wwe-drone-racing-league.html\" target=\"_blank\">closed new funding</a>, now with participation from World Wrestling Entertainment (<a href=\"http://seekingalpha.com/symbol/WWE\" target=\"_blank\">WWE</a> <font color='green'>+1.6%</font>).</li>    <li>The wrestling company joins in with Liberty Media (<a href=\"http://seekingalpha.com/symbol/FWONA\" target=\"_blank\">FWONA</a> <font color='green'>+0.8%</font>), Sky (<a href=\"http://seekingalpha.com/symbol/SKYAY\" target=\"_blank\">SKYAY</a> <font color='green'>+0.9%</font>) and venture firm Lux Capital as leaders in the $20M Series B round.</li>    <li>Insurer Allianz is the Drone Racing League's global title sponsor.</li>    <li>Six races to test drone piloting skill are set to start airing on broadcast channels including Sky Sports and ESPN in more than 75 countries on June 20.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273267\" data-linked=\"WWE joins Liberty in funding Drone Racing League\" data-tweet=\"$WWE $WWE $FWONA - WWE joins Liberty in funding Drone Racing League https://seekingalpha.com/news/3273267-wwe-joins-liberty-in-funding-drone-racing-league?source=tweet\" data-url=\"https://seekingalpha.com/news/3273267-wwe-joins-liberty-in-funding-drone-racing-league\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273261\" data-ts=\"1497380560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273261-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a> <font color='green'>+58%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/PRKR' title='ParkerVision, Inc.'>OTC:PRKR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZIXI' title='Zix Corporation'>ZIXI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SGMA' title='SigmaTron International, Inc.'>SGMA</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273261\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$MOSY $ABIL $INPX - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3273261-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273261-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273250\" data-ts=\"1497377809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMC\" target=\"_blank\">CMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273250-commercial-metals-to-sell-raw-materials-trading-division-upgraded-citi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial Metals to sell raw materials trading division; upgraded at Citi</a></h4><ul>     <li>Commercial Metals (<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+3.5%</font>) maintains strong gains on news it is exiting its International Marketing and Distribution segment, <a href=\"https://seekingalpha.com/pr/16860015-commercial-metals-company-exit-international-marketing-distribution-segment-signs-definitive\" target=\"_blank\">selling its raw materials trading division</a> to Carlyle Group affiliates as an initial step; financial terms are not provided.</li>     <li>CMC also says it plans to pursue a sale of its Texas-based CMC Cometals Steel division, which markets steel products, as well as a restructuring and sale of the remaining trading operations located in Asia and Australia.</li>     <li>Separately, shares are <a href=\"http://thefly.com/thestreet/realmoney/index.php/CMCid2565781/CMC-Commercial-Metals-upgraded-to-Buy-from-Neutral-at-Citi\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $22 price target, raised from $21, at Citigroup, citing upside potential from <a href=\"https://seekingalpha.com/news/3269726-foreign-steel-imports-imperil-u-s-national-security-steel-giants-warn-hearing\" target=\"_blank\">Section 232 trade action</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273250\" data-linked=\"Commercial Metals to sell raw materials trading division; upgraded at Citi\" data-tweet=\"$CMC - Commercial Metals to sell raw materials trading division; upgraded at Citi https://seekingalpha.com/news/3273250-commercial-metals-to-sell-raw-materials-trading-division-upgraded-citi?source=tweet\" data-url=\"https://seekingalpha.com/news/3273250-commercial-metals-to-sell-raw-materials-trading-division-upgraded-citi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273248\" data-ts=\"1497377327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HA\" target=\"_blank\">HA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273248-hawaiian-holdings-lower-after-ual-adds-flights-to-hawaii\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hawaiian Holdings lower after UAL adds flights to Hawaii</a></h4><ul> <li>Shares of Hawaiian Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a>)&nbsp;are <font color='red'>down 4.33%</font> after United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='red'>-0.8%</font>) says it will <a href=\"https://seekingalpha.com/pr/16860461-united-airlines-says-aloha-hawaii-increases-service-40-daily-flights\" target=\"_blank\">add</a> some Hawaiian Island flights from the U.S.</li> <li>The company says 11 routes connecting the continental U.S. and Hawaii will additional new flights.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3273248\" data-linked=\"Hawaiian Holdings lower after UAL adds flights to Hawaii\" data-tweet=\"$HA $HA $UAL - Hawaiian Holdings lower after UAL adds flights to Hawaii https://seekingalpha.com/news/3273248-hawaiian-holdings-lower-after-ual-adds-flights-to-hawaii?source=tweet\" data-url=\"https://seekingalpha.com/news/3273248-hawaiian-holdings-lower-after-ual-adds-flights-to-hawaii\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273246\" data-ts=\"1497376862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273246-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling'>ICD</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273246\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$IPI $KLDX $SM - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3273246-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273246-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273244\" data-ts=\"1497375845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCLRY\" target=\"_blank\">TCLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273244-nokia-technicolor-partnering-on-vr-content-creation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia, Technicolor partnering on VR content creation</a></h4><ul>   <li>Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color='green'>+1.4%</font>) and Technicolor (<a href='https://seekingalpha.com/symbol/TCLRY' title='Technicolor SA ADR'>OTCQX:TCLRY</a>) have established a <a href=\"https://finance.yahoo.com/news/nokia-technicolor-announce-immersive-vr-160131557.html\" target=\"_blank\">partnership</a> to build immersive virtual reality content using Nokia's VR camera.</li>    <li>The OZO+ camera will be featured at the Technicolor Experience Center in Los Angeles, and the companies will use the camera and OZO content creation tools to build content and educational material.</li>    <li>The first project in the partnership will be a series of master classes set at the TEC to train professionals on creating VR films.</li>    <li><a href='https://seekingalpha.com/symbol/THNRF' title='Technicolor SA'>OTCPK:THNRF</a> is <font color='green'>up 20.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273244\" data-linked=\"Nokia, Technicolor partnering on VR content creation\" data-tweet=\"$TCLRY $TCLRY $THNRF - Nokia, Technicolor partnering on VR content creation https://seekingalpha.com/news/3273244-nokia-technicolor-partnering-on-vr-content-creation?source=tweet\" data-url=\"https://seekingalpha.com/news/3273244-nokia-technicolor-partnering-on-vr-content-creation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273243\" data-ts=\"1497375804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCT\" target=\"_blank\">CMCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273243-day-2-of-gains-for-cim-commercial-trust\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Day 2 of gains for CIM Commercial Trust</a></h4><ul><li>The company yesterday <a href=\"https://seekingalpha.com/pr/16858563-cim-commercial-trust-announces-private-repurchase-26181-818-shares-declares-special-regular\" target=\"_blank\">morning announced the</a> repurchase of 26.2M shares of common stock from its external manager for $22 per share. Alongside, the company is paying a special dividend of $1.98 per share, with the external manager waiving its right to receive the special payout on common stock it owns.</li><li><a href='https://seekingalpha.com/symbol/CMCT' title='CIM Commercial Trust Corp.'>CMCT</a>&nbsp;<font color='green'>+12%</font>&nbsp;today to $18.98.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273243\" data-linked=\"Day 2 of gains for CIM Commercial Trust\" data-tweet=\"$CMCT - Day 2 of gains for CIM Commercial Trust https://seekingalpha.com/news/3273243-day-2-of-gains-for-cim-commercial-trust?source=tweet\" data-url=\"https://seekingalpha.com/news/3273243-day-2-of-gains-for-cim-commercial-trust\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273239\" data-ts=\"1497373763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273239-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CMCT' title='CIM Commercial Trust Corp.'>CMCT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TRCB' title='Two River Bancorp'>TRCB</a> <font color='green'>+7%</font>.<a href='https://seekingalpha.com/symbol/TSBK' title='Timberland Bancorp, Inc.'>TSBK</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273239\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$CMCT $TRCB $TSBK - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3273239-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273239-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273234\" data-ts=\"1497372959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273234-ibm-hortonworks-extend-data-science-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, Hortonworks extend data science partnership</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) and Hortonworks (NASDAQ:<a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a>) <a href=\"http://www.prnewswire.com/news-releases/ibm-hortonworks-expand-partnership-to-help-businesses-accelerate-data-driven-decision-making-300473226.html\" target=\"_blank\">announce</a> an expansion of the data science and machine learning partnership to allow customers to analyze and manage large volumes of data across the Apache Hadoop ecosystem.</li><li>               The integrated solution fuses Hortonworks Data Platform with IBM&rsquo;s Data Science Experience and Big SQL. Each company will sell the others&rsquo; products as parts of their own official product line.</li><li>Hortonworks shares are&nbsp;<font color='green'>up 7.12%</font>. &nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3273234\" data-linked=\"IBM, Hortonworks extend data science partnership\" data-tweet=\"$IBM $IBM $HDP - IBM, Hortonworks extend data science partnership https://seekingalpha.com/news/3273234-ibm-hortonworks-extend-data-science-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3273234-ibm-hortonworks-extend-data-science-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273232\" data-ts=\"1497372449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273232-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a> <font color='green'>+60%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+22%</font>. CLNT <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CMCT' title='CIM Commercial Trust Corp.'>CMCT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='red'>-19%</font>. PSDV <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CAKE' title='The Cheesecake Factory Incorporated'>CAKE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ZIXI' title='Zix Corporation'>ZIXI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273232\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$MOSY $DRYS $SEII - Midday Gainers / Losers https://seekingalpha.com/news/3273232-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273232-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273230\" data-ts=\"1497372444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273230-redhill-bio-launches-two-gi-products-in-u-s-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill Bio launches two GI products in U.S., shares up 3%</a></h4><ul><li>Thinly traded micro cap RedHill Biopharma (<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='green'>+2.5%</font>) perks up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16859963-redhill-biopharma-initiates-promotion-donnatal-enteragam-u-s\" target=\"_blank\">announcement </a>that it has commenced promoting two GI-focused products in the U.S.: Donnatal (phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide) for the adjunctive treatment of irritable bowel syndrome and EnteraGam (serum-derived bovine immunoglobulin/protein isolate, SBI) for the dietary management of chronic diarrhea and loose stools.</li><li>The company has an exclusive co-promotion agreement with Concordia International (<a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a> <font color='green'>+1.2%</font>) for Donnatal under which they will share revenues. It exclusively licensed EnteraGam from Entera Health and will pay royalties on net sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273230\" data-linked=\"RedHill Bio launches two GI products in U.S., shares up 3%\" data-tweet=\"$RDHL $RDHL $CXRX-OLD - RedHill Bio launches two GI products in U.S., shares up 3% https://seekingalpha.com/news/3273230-redhill-bio-launches-two-gi-products-in-u-s-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3273230-redhill-bio-launches-two-gi-products-in-u-s-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273226\" data-ts=\"1497371049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273226-omeros-oms721-breakthrough-therapy-for-kidney-disorders-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros&#39; OMS721 a Breakthrough Therapy for kidney disorders; shares ahead 10%</a></h4><ul><li>Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+10.4%</font>) follows through on yesterday's upmove on triple normal volume. Share had rallied almost 30% before retracing.</li><li>The catalyst appears to be the FDA's <a href=\"https://seekingalpha.com/pr/16860632-fda-grants-breakthrough-therapy-designation-omeros-maspminus-2-inhibitor-oms721-treatment-iga\" target=\"_blank\">designation </a>of Breakthrough Therapy &#40;BTD&#41;&nbsp;status to lead monoclonal antibody candidate OMS721 for the treatment of IgA nephropathy.</li><li>BTD provides for more intensive guidance from the FDA, the involvement of more senior agency personnel and a rolling review of the marketing application.</li><li>Phase 2-stage OMS721 binds to an enzyme called mannan-binding lectin-associated serine protease-2 (<a href=\"http://www.omeros.com/pipeline/masp.htm\" target=\"_blank\">MASP-2</a>) which plays a key role in the lectin pathway of the complement system, which is believed to contribute to significant tissue injury.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247607-omeros-announces-additional-positive-data-mid-stage-study-oms721-shares-ahead-3-percent\" target=\"_blank\">Omeros announces additional positive data from mid-stage study of OMS721; shares ahead 3% premarket</a> (March 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273226\" data-linked=\"Omeros&#39; OMS721 a Breakthrough Therapy for kidney disorders; shares ahead 10%\" data-tweet=\"$OMER - Omeros&#39; OMS721 a Breakthrough Therapy for kidney disorders; shares ahead 10% https://seekingalpha.com/news/3273226-omeros-oms721-breakthrough-therapy-for-kidney-disorders-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3273226-omeros-oms721-breakthrough-therapy-for-kidney-disorders-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273224\" data-ts=\"1497370494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANDV\" target=\"_blank\">ANDV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273224-tesoroplus-2-goldman-adds-to-conviction-buy-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesoro +2% as Goldman adds to Conviction Buy List</a></h4><ul>     <li>Tesoro (TSO <font color='green'>+2.4%</font>) is higher after Goldman Sachs <a href=\"https://www.thestreet.com/story/14176723/1/tesoro-stock-jumps-on-goldman-conviction-buy-addition.html\" target=\"_blank\">adds the stock to its Conviction Buy List</a> with a $121 price target, saying it remains undervalued and can generate solid cash flow.</li>     <li>The firm says TSO's acquisition of Western Refining could drive earnings improvement from \"better Permian crude access, higher product pricing and $100M-$125M in cost reductions.\"</li>     <li>To reach the six-month $121 price target, Goldman estimates $55 of value comes from retail and marketing, $48 comes from logistics and TLLP, while marketing provides a source of constant cash flow and logistics generates $11/share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273224\" data-linked=\"Tesoro +2% as Goldman adds to Conviction Buy List\" data-tweet=\"$ANDV $ANDV $ANDX - Tesoro +2% as Goldman adds to Conviction Buy List https://seekingalpha.com/news/3273224-tesoroplus-2-goldman-adds-to-conviction-buy-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3273224-tesoroplus-2-goldman-adds-to-conviction-buy-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273223\" data-ts=\"1497369816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MC\" target=\"_blank\">MC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273223-moelis-up-4_5-after-surprise-special-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moelis up 4.5% after surprise special dividend</a></h4><ul><li>While special dividends are part of the routine for Moelis (NYSE:<a href='https://seekingalpha.com/symbol/MC' title='Moelis & Company'>MC</a>), last night's $1 per share announcement was a surprise given the $1.25 special payout five months ago.</li><li>Shares are<font color='green'> up 4.45%</font>&nbsp;today,&nbsp;<font color='green'>14%</font>&nbsp;for the year, and&nbsp;<font color='green'>52%</font>&nbsp;Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273011-moelis-declares-1_00-dividend\" target=\"_blank\">Moelis declares $1.00 dividend</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273223\" data-linked=\"Moelis up 4.5% after surprise special dividend\" data-tweet=\"$MC - Moelis up 4.5% after surprise special dividend https://seekingalpha.com/news/3273223-moelis-up-4_5-after-surprise-special-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3273223-moelis-up-4_5-after-surprise-special-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273222\" data-ts=\"1497369676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273222-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/JVA' title='Coffee Holding Co., Inc'>JVA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273222\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$TIS $VRS $ESND - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3273222-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273222-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273218\" data-ts=\"1497369491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRM\" target=\"_blank\">STRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273218-streamline-health-q1-top-line-down-11-shares-ease-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Streamline Health Q1 top line down 11%; shares ease 8%</a></h4><ul><li>Streamline Health Solutions (<a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-8.3%</font>) <a href=\"https://seekingalpha.com/pr/16859442-streamline-health-reports-first-quarter-2017-revenues-5_9-million-2_0-million-net-loss\" target=\"_blank\">Q1 results</a> ($M): Revenues: 5.9 (-11.2%); SAAS: 1.4 (-16.7%); Net Loss: (2.0) (+9.7%); Loss/Share: (0.10) (flat); Quick Assets: &nbsp;3.6 (-36.7%); CF Ops: (1.5) (+40.8%).</li><li>CEO David Sides says, \"Our first quarter financial performance was as previously communicated, with a decline in revenue from Q4 of 2016 based primarily upon the anticipated revenue attrition of approximately $0.5 million combined with the negative net effect of selling our Scheduling solution suite while adding code auditing services. However, as we look at the remainder of the year, we are encouraged by the sales activity we are experiencing primarily with our new cloud-based pre-bill audit solution we call eValuator&trade;.&nbsp;We acquired the initial concept for this new solution in September, invested development resources into it in the second half of last year and formally launched it at the HIMSS conference in February.&nbsp; In just four months, the top of our sales pipeline has expanded substantially with more than 50 current clients and new prospects interested in eValuator. We anticipate closing our first of several new contracts in this quarter, and ramping up our bookings and recurring revenue performance in subsequent quarters this year and next.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3273218\" data-linked=\"Streamline Health Q1 top line down 11%; shares ease 8%\" data-tweet=\"$STRM - Streamline Health Q1 top line down 11%; shares ease 8% https://seekingalpha.com/news/3273218-streamline-health-q1-top-line-down-11-shares-ease-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3273218-streamline-health-q1-top-line-down-11-shares-ease-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273217\" data-ts=\"1497369132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SODA\" target=\"_blank\">SODA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273217-sodastream-perks-up-after-ceo-nabs-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SodaStream perks up after CEO nabs shares</a></h4><ul> <li>SodaStream (<a href='https://seekingalpha.com/symbol/SODA' title='SodaStream International'>SODA</a> <font color='green'>+4.4%</font>) CEO Daniel Birnbaum picked up 20K shares on June 12 at an average price of $50.41.</li> <li><a href=\"https://seekingalpha.com/filing/3592043\" target=\"_blank\">SEC Form 6-K</a></li> <li>Shares of SodaStream have been dancing around in a range of $50 to $55 for about a month.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273217\" data-linked=\"SodaStream perks up after CEO nabs shares\" data-tweet=\"$SODA - SodaStream perks up after CEO nabs shares https://seekingalpha.com/news/3273217-sodastream-perks-up-after-ceo-nabs-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3273217-sodastream-perks-up-after-ceo-nabs-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273215\" data-ts=\"1497368247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJR\" target=\"_blank\">SJR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273215-shawplus-5_1-on-deals-to-sell-viawest-buy-spectrum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shaw +5.1% on deals to sell ViaWest, buy spectrum</a></h4><ul>   <li>Shaw Communications (NYSE:<a href='https://seekingalpha.com/symbol/SJR' title='Shaw Communications Inc.'>SJR</a>) is <font color='green'>up 5.1%</font> in U.S. trading following news it's <a href=\"https://seekingalpha.com/news/3273129-shaw-sell-viawest-subsidiary\" target=\"_blank\">selling</a> its ViaWest data/cloud unit to Peak 10 for about C$2.3B (about $1.74B), and <a href=\"https://seekingalpha.com/pr/16859987-shaw-communications-inc-announces-acquisition-700-mhz-2500-mhz-wireless-spectrum-licences\" target=\"_blank\">using proceeds to buy wireless airwaves</a>.</li>    <li>The company had bought ViaWest from private-equity owners in 2014 for about $1.2B but began <a href=\"https://seekingalpha.com/news/3261523-reuters-shaw-communications-floating-sale-viawest\" target=\"_blank\">shopping the unit this spring</a> as part of an ongoing refocus on core business.</li>    <li>Shaw will boost its nascent wireless unit by spending about C$430M on new spectrum licenses in the 700 MHz and 2.5 GHz bands from Quebecor (<a href='https://seekingalpha.com/symbol/QBCAF' title='Quebecor Inc.A'>OTC:QBCAF</a>). Shaw will use the new spectrum in its home markets of Alberta and British Columbia as well as southern Ontario.</li>    <li>Quebecor A shares are <font color='green'>up 1.8%</font> in Toronto; B shares are <font color='green'>up 1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273215\" data-linked=\"Shaw +5.1% on deals to sell ViaWest, buy spectrum\" data-tweet=\"$SJR $SJR $QBCAF - Shaw +5.1% on deals to sell ViaWest, buy spectrum https://seekingalpha.com/news/3273215-shawplus-5_1-on-deals-to-sell-viawest-buy-spectrum?source=tweet\" data-url=\"https://seekingalpha.com/news/3273215-shawplus-5_1-on-deals-to-sell-viawest-buy-spectrum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273212\" data-ts=\"1497367737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273212-reuters-taiwan-to-get-first-lng-shipment-from-u-s-sabine-pass\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Taiwan to get first LNG shipment from U.S. Sabine Pass</a></h4><ul>     <li>With the <a href=\"http://www.reuters.com/article/us-usa-cheniere-lng-idUSKBN1932IN\" target=\"_blank\">imminent arrival of a tanker in Taiwan</a>, the U.S. will increase the number of countries that have received liquefied natural gas from Cheniere Energy's (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc'>LNG</a> <font color='red'>-1.6%</font>) Sabine Pass terminal in Louisiana to at least 23 of the 35 that can accept the vessels, according to Reuters shipping data.</li>     <li>In May, eight vessels picked up cargoes from Sabine Pass with a total capacity of ~59.5B cf, going to several countries including Brazil, United Arab Emirates, Mexico, China, South Korea, Argentina and the first exports to the Netherlands and Poland.</li>     <li>Based on an average price of $3.12/MMBtu at the Henry Hub benchmark in Louisiana in May, the value of gas shipped from Sabine last month totaled ~$192M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273212\" data-linked=\"Reuters: Taiwan to get first LNG shipment from U.S. Sabine Pass\" data-tweet=\"$LNG - Reuters: Taiwan to get first LNG shipment from U.S. Sabine Pass https://seekingalpha.com/news/3273212-reuters-taiwan-to-get-first-lng-shipment-from-u-s-sabine-pass?source=tweet\" data-url=\"https://seekingalpha.com/news/3273212-reuters-taiwan-to-get-first-lng-shipment-from-u-s-sabine-pass\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273208\" data-ts=\"1497366983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273208-cytrx-shakes-up-clinical-and-regulatory-leadership-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx shakes up clinical and regulatory leadership; shares ahead 10%</a></h4><ul><li>CytRx (<a href='https://seekingalpha.com/symbol/CYTR' title='CytRx Corporation'>CYTR</a> <font color='green'>+9.9%</font>) <a href=\"https://seekingalpha.com/pr/16860212-cytrx-announces-reshaping-clinical-regulatory-executive-team\" target=\"_blank\">announces </a>changes its its executive team responsible for clinical and regulatory functions.</li><li>VP of Clinical Development Shanta Chawla, M.D. is promoted to SVP of Drug Development with responsibility for regulatory activities and ongoing clinical drug development.</li><li>COO and Chief Medical Officer Daniel Levitt, M.D., Ph.D., will step down effective July 7. No successor is planned.</li><li>SVP of Drug Development Scott Weiland, Ph.D., will step down June 30.</li><li>Hurley Consulting Associates will continue to assist in the preparation of the U.S. marketing application for aldoxorubicin for soft tissue sarcomas.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273208\" data-linked=\"CytRx shakes up clinical and regulatory leadership; shares ahead 10%\" data-tweet=\"$CYTR - CytRx shakes up clinical and regulatory leadership; shares ahead 10% https://seekingalpha.com/news/3273208-cytrx-shakes-up-clinical-and-regulatory-leadership-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3273208-cytrx-shakes-up-clinical-and-regulatory-leadership-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273205\" data-ts=\"1497366397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273205-frontier-up-6_1-sets-800m-in-debt-tender-offers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier up 6.1% as it sets $800M in debt tender offers</a></h4><ul>   <li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is <font color='green'>up 6.1%</font> after word of cash tender offers for <a href=\"https://seekingalpha.com/pr/16859553-frontier-communications-announces-cash-tender-offers-800-million-aggregate-maximum\" target=\"_blank\">up to $800M in debt</a>.</li>    <li>The company will fund the tenders via a new term loan B facility that it will enter into prior to the tenders' early settlement date.</li>    <li>Frontier lists six series of notes. Top priority goes to 8.875% senior notes due 2020, of which there's $1.07B outstanding; with an early tender premium of $50, total consideration per $1,000 principal is $1,062.50.</li>    <li>The company's also offering $1,060 per $1,000 principal for 8.5% senior notes due 2020 ($1.17B outstanding), and $1,017.50 per $1,000 principal for 9.25% senior notes due 2021.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273205\" data-linked=\"Frontier up 6.1% as it sets $800M in debt tender offers\" data-tweet=\"$FTR - Frontier up 6.1% as it sets $800M in debt tender offers https://seekingalpha.com/news/3273205-frontier-up-6_1-sets-800m-in-debt-tender-offers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273205-frontier-up-6_1-sets-800m-in-debt-tender-offers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273179\" data-ts=\"1497366057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273179-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PRTO' title='Proteon Therapeutics'>PRTO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MEIP' title='MEI Pharma, Inc.'>MEIP</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='red'>-12%</font>. PSDV <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/IVTY' title='Invuity'>IVTY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273179\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$NK $PRTO $NURO - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3273179-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3273179-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273201\" data-ts=\"1497365610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273201-loonie-surge-continues-investors-price-in-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loonie surge continues as investors price in rate hike</a></h4><ul><li>Comments yesterday from the Bank of Canada's Carolyn Wilkins startled the status quo as she suggested a rate hike could be nearer than nearly all imagined. Her words sent the loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) sharply higher vs. the greenback, and it's&nbsp;<font color='green'>ahead another 1.4%&nbsp;</font>today to its strongest level since late February.</li><li>A check of short-term rate futures up North <a href=\"https://www.ft.com/content/a49c1408-6a01-3ff3-8d14-9826c19b1ae9\" target=\"_blank\">finds the odds of a rate hike</a> at some point this year up to 62% today vs. 29% at the end of last week (the BoC's last rate hike was seven years ago).</li><li>Scotiabank says at least &nbsp;part of the loonie's liftoff is thanks to catching shorts unaware. Still, the team thinks the currency has more room to run, particularly as the Fed may pause its tightening cycle after hiking later this week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3272974-bank-canada-official-talks-rate-hike-loonie-surges\" target=\"_blank\">Bank of Canada official talks rate hike -  loonie surges</a> (June 12)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273201\" data-linked=\"Loonie surge continues as investors price in rate hike\" data-tweet=\"$FXC $EWC $CNDA - Loonie surge continues as investors price in rate hike https://seekingalpha.com/news/3273201-loonie-surge-continues-investors-price-in-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3273201-loonie-surge-continues-investors-price-in-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273197\" data-ts=\"1497365293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273197-yahoo-era-ends-verizon-closes-4_48b-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yahoo era ends as Verizon closes $4.48B buyout</a></h4><ul>   <li>Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='red'>-0.9%</font>) has closed on its $4.476B acquisition of Yahoo's (<a href=\"http://seekingalpha.com/symbol/YHOO\" target=\"_blank\">YHOO</a> <font color='red'>-1.1%</font>) core business, bringing to a symbolic end the saga of the sale of an Internet pioneer, and launching a pair of new enterprises each with a different focus.</li>    <li>As planned, Yahoo and its Internet assets will join with dozens of other Verizon brands (including HuffPost, AOL, Tumblr and others) under Oath, a new subsidiary.</li>    <li>\"The combined set of assets across Verizon and Oath, from VR to AI, 5G to IoT, from content partnerships to originals, will create exciting new ways to captivate audiences across the globe,\" says Verizon's Marni Walden.</li>    <li>Meanwhile, what's left of Yahoo will register as an investment company, Altaba, to manage a stake of about 15% in Alibaba (<a href=\"http://seekingalpha.com/symbol/BABA\" target=\"_blank\">BABA</a> <font color='red'>-0.4%</font>) and of about 36% in Yahoo Japan (<a href=\"http://seekingalpha.com/symbol/YAHOY\" target=\"_blank\">YAHOY</a> <font color='red'>-2.7%</font>), along with cash and equivalents, some minority investments, and patent holding unit Excalibur.</li>    <li>With the closing, David Filo, Eddy Hartenstein, Richard Hill, Marissa Mayer, Jane Shaw, Jeffrey Smith and Maynard Webb Jr. resigned from the Yahoo/Altaba board, leaving Chairman Eric Brandt, Tor Braham, Catherine Friedman and Thomas McInerney (who will become CEO).</li>    <li>Altaba will trade on Nasdaq under YHOO through Friday; starting Monday, it will trade under ticker <a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a> (no action required by stockholders).</li>    <li><a href=\"https://seekingalpha.com/pr/16860484-yahoo-completes-sale-operating-business-company-re-named-altaba-register-investment-company\" target=\"_blank\">Yahoo statement</a></li>    <li><a href=\"https://seekingalpha.com/pr/16860492-verizon-completes-yahoo-acquisition-creating-diverse-house-50-plus-brands-new-oath-subsidiary\" target=\"_blank\">Verizon statement</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3273197\" data-linked=\"Yahoo era ends as Verizon closes $4.48B buyout\" data-tweet=\"$VZ $VZ $AABA - Yahoo era ends as Verizon closes $4.48B buyout https://seekingalpha.com/news/3273197-yahoo-era-ends-verizon-closes-4_48b-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3273197-yahoo-era-ends-verizon-closes-4_48b-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273192\" data-ts=\"1497364451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JW.A\" target=\"_blank\">JW.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273192-john-wileyplus-4-solutions-unit-paces-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">John Wiley +4% as Solutions unit paces Q4 beat</a></h4><ul>   <li>John Wiley &amp; Sons (NYSE:<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a>) is <font color='green'>up 4%</font> after <a href=\"https://seekingalpha.com/news/3273120-john-wiley-and-sons-beats-0_28-beats-revenue\" target=\"_blank\">Q4 earnings</a> showed a solid beat on top and bottom lines with strength in its Solutions business.</li>    <li>That business grew revenue in double digits over the fiscal year along with \"substantial\" profit improvement, while the Research business grew in line, marginally positive.</li>    <li>Revenue by segment: Research, $234.5M (up 3% excluding forex); Publishing, $153.75M (up 7%); Solutions, $63.95M (up 14%).</li>    <li>For fiscal 2018, the company is anticipating revenue growth of low single digits in Research and low double digits in Solutions, along with a decline in high single digits in Publishing as print book markets continue to erode.</li>    <li>Overall it sees revenue and operating income both flat at constant currency, and EPS down low single digits mainly due to 2017's nonrecurring tax benefits. Capex will be slightly lower.</li>    <li><a href=\"https://seekingalpha.com/pr/16859909-wiley-reports-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3273192\" data-linked=\"John Wiley +4% as Solutions unit paces Q4 beat\" data-tweet=\"$JW.A $JW.B - John Wiley +4% as Solutions unit paces Q4 beat https://seekingalpha.com/news/3273192-john-wileyplus-4-solutions-unit-paces-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3273192-john-wileyplus-4-solutions-unit-paces-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273188\" data-ts=\"1497364158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESNC\" target=\"_blank\">ESNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273188-ensync-schneider-explore-opportunities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnSync, Schneider explore opportunities</a></h4><ul><li>EnSync (NYSEMKT:<a href='https://seekingalpha.com/symbol/ESNC' title='EnSync, Inc.'>ESNC</a>) <font color='green'>+27%</font> in early trade after <a href=\"http://www.prnewswire.com/news-releases/ensync-energy-and-schneider-electric-to-explore-distributed-energy-resource-technology-and-market-opportunities-300472518.html\" target=\"_blank\">stating</a> it will explore technology and opportunities in the distributed energy resources market with Schneider Electric.</li><li>After reviewing EnSync's Matrix Energy System, the two companies identified areas of mutual interest for collaboration.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273188\" data-linked=\"EnSync, Schneider explore opportunities\" data-tweet=\"$ESNC - EnSync, Schneider explore opportunities https://seekingalpha.com/news/3273188-ensync-schneider-explore-opportunities?source=tweet\" data-url=\"https://seekingalpha.com/news/3273188-ensync-schneider-explore-opportunities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273184\" data-ts=\"1497362952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVTY\" target=\"_blank\">IVTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273184-invuity-recalls-photonblade-due-to-safety-concerns-shares-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invuity recalls PhotonBlade due to safety concerns; shares down 9%</a></h4><ul><li>Thinly traded micro cap Invuity (<a href='https://seekingalpha.com/symbol/IVTY' title='Invuity'>IVTY</a> <font color='red'>-8.6%</font>) slumps on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16859956-invuity-provides-update-photonblade-commercialization\" target=\"_blank\">announcement </a>that it will voluntarily recall the <a href=\"http://invuity.com/products/photonblade/\" target=\"_blank\">PhotonBlade </a>units from the field that it placed during the limited market introduction that began in March. The company it needs to refine the product after receiving reports of unintended energy discharge that could potentially damage tissue. Shipments should resume next quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273184\" data-linked=\"Invuity recalls PhotonBlade due to safety concerns; shares down 9%\" data-tweet=\"$IVTY - Invuity recalls PhotonBlade due to safety concerns; shares down 9% https://seekingalpha.com/news/3273184-invuity-recalls-photonblade-due-to-safety-concerns-shares-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3273184-invuity-recalls-photonblade-due-to-safety-concerns-shares-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273181\" data-ts=\"1497362391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MONIF\" target=\"_blank\">MONIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273181-monitiseplus-16_7-on-fiservs-cash-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monitise +16.7% on Fiserv&#39;s cash buyout</a></h4><ul>   <li>Monitise Plc (<a href='https://seekingalpha.com/symbol/MONIF' title='Monitise PLC'>OTC:MONIF</a>) is <font color='green'>up 16.7%</font> in U.S. trading after word of Fiserv's (FISV +0.3%) <a href=\"https://seekingalpha.com/news/3273077-fiserv-acquire-monitise-plc-70m\" target=\"_blank\">&pound;70M cash deal</a> to acquire the company.</li>    <li>Monitise is <font color='green'>up 22.3%</font> in London to 2.81 pence vs. the 2.90-pence deal price.</li>    <li>After hitting $1.35 in U.S. trading in March 2014, shares began a precipitous decline, dropping under $0.40 by that year's end and <a href=\"https://seekingalpha.com/news/2774286-deathwatch-grows-monitise-grim-results\" target=\"_blank\">dropping to $0.041 by the end of 2015</a> as many investors looked for some kind of takeout. Previous large stakeholder Visa began unloading a 15% ownership in 2014.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273181\" data-linked=\"Monitise +16.7% on Fiserv&#39;s cash buyout\" data-tweet=\"$MONIF - Monitise +16.7% on Fiserv&#39;s cash buyout https://seekingalpha.com/news/3273181-monitiseplus-16_7-on-fiservs-cash-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3273181-monitiseplus-16_7-on-fiservs-cash-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273178\" data-ts=\"1497361824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DATA\" target=\"_blank\">DATA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273178-goldman-sachs-upgrades-tableau-software-shares-up-nearly-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs upgrades Tableau Software; shares up nearly 4%</a></h4><ul><li>        Goldman Sachs <a href=\"https://www.streetinsider.com/Special+Reports/Pre-Open+Movers+0613%3A+%28CLNT%29+%28DATA%29+%28MNK%29+%28TLSA%29+Higher%3B+%28CIE%29+%28SAIC%29+%28CAKE%29+Lower+%28more...%29/13006283.html\" target=\"_blank\">upgrades</a> Tableau Software (NYSE:<a href='https://seekingalpha.com/symbol/DATA' title='Tableau Software'>DATA</a>) from Hold to Buy with a $78 price target, up from $59.</li><li>               Tableau&rsquo;s latest analyst standings: 7 Buy, 7 Outperform, 17 Hold, 2 Underperform, and 1 Sell.&nbsp;</li><li>               Median price target: $65.&nbsp;</li><li>               Tableau Software shares are&nbsp;<font color='green'>up 3.94%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3273178\" data-linked=\"Goldman Sachs upgrades Tableau Software; shares up nearly 4%\" data-tweet=\"$DATA - Goldman Sachs upgrades Tableau Software; shares up nearly 4% https://seekingalpha.com/news/3273178-goldman-sachs-upgrades-tableau-software-shares-up-nearly-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3273178-goldman-sachs-upgrades-tableau-software-shares-up-nearly-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273166\" data-ts=\"1497360354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEII\" target=\"_blank\">SEII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273166-cleantechplus-25-on-news-of-potential-takeover-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleantech +25% on news of potential takeover talks</a></h4><ul>     <li>Cleantech Solutions (CLNT) <font color='green'>+24.8%</font> premarket after announcing it <a href=\"https://seekingalpha.com/pr/16859342-cleantech-solutions-international-enters-agreement-ecrent-china-sharing-economy-platform\" target=\"_blank\">entered into talks</a> with ECrent Capital Holdings, with plans to develop and operate a global rental platform to promote sharing economy across 30  countries and regions.</li><li>CLNT says it will form an independent committee to evaluate and negotiate a potential acquisition or business cooperation with  ECrent.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273166\" data-linked=\"Cleantech +25% on news of potential takeover talks\" data-tweet=\"$SEII - Cleantech +25% on news of potential takeover talks https://seekingalpha.com/news/3273166-cleantechplus-25-on-news-of-potential-takeover-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3273166-cleantechplus-25-on-news-of-potential-takeover-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273164\" data-ts=\"1497359889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADC\" target=\"_blank\">ADC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273164-agree-realtyminus-1_2-after-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agree Realty -1.2% after share sale</a></h4><ul><li>According to Bloomberg, Agree Realty's (NYSE:<a href='https://seekingalpha.com/symbol/ADC' title='Agree Realty Corporation'>ADC</a>) 2.1M secondary offering priced at $46.45 each.</li><li>Shares&nbsp;<font color='red'>-1.2%</font>&nbsp;premarket to $47.09.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273008-agree-realty-raising-equity-capital\" target=\"_blank\">Agree Realty raising equity capital</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273164\" data-linked=\"Agree Realty -1.2% after share sale\" data-tweet=\"$ADC - Agree Realty -1.2% after share sale https://seekingalpha.com/news/3273164-agree-realtyminus-1_2-after-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3273164-agree-realtyminus-1_2-after-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273161\" data-ts=\"1497359693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMG\" target=\"_blank\">SMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273161-scotts-miracle-gro-cuts-full-year-guidance-sharesminus-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scotts Miracle-Gro cuts full-year guidance, shares -3% premarket</a></h4><ul><li>Scotts Miracle-Gro (NYSE:<a href='https://seekingalpha.com/symbol/SMG' title='The Scotts Miracle-Gro Company'>SMG</a>) <font color='red'>-2.9%</font> premarket after <a href=\"https://seekingalpha.com/pr/16859828-scottsmiracle-gro-updates-fiscal-2017-sales-adjusted-eps-outlook\" target=\"_blank\">lowering its FY 2017 guidance</a>, citing a greater than 10% decline in performance in the mass  retail segment due to changes in merchandising  strategies and tighter inventory management.</li><li>SMG now sees FY 2017 EPS of $4.00-$4.20, vs. previous guidance of $4.10-$4.30 and $4.19 analyst consensus estimate, with revenue growth of 3%-4% vs. earlier guidance of 6%-7% to $2.92B-$2.95B and $2.98B consensus.</li><li>SMG also says it has increased its share repurchase activity in recent  weeks, and expects to buy back $250M-$275M of shares on a full-year basis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273161\" data-linked=\"Scotts Miracle-Gro cuts full-year guidance, shares -3% premarket\" data-tweet=\"$SMG - Scotts Miracle-Gro cuts full-year guidance, shares -3% premarket https://seekingalpha.com/news/3273161-scotts-miracle-gro-cuts-full-year-guidance-sharesminus-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3273161-scotts-miracle-gro-cuts-full-year-guidance-sharesminus-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273160\" data-ts=\"1497359672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273160-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+21%</font>.</li><li><a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='green'>+18%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3273107-neurometrix-awarded-new-u-s-patent-covering-quell-pain-relief-device-shares-ahead-5-percent\" target=\"_blank\">awarded</a> new U.S. patent covering Quell pain relief device.</li><li><a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273130-grant-news-lifts-magnegas-shares\" target=\"_blank\">receiving</a>&nbsp;a $431,874 grant from the U.S Department of Agriculture.</li><li><a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16860276-pulmatrix-licenses-novel-drug-candidates-respivert-ltd-wholly-owned-subsidiary-janssen\" target=\"_blank\">entering</a> into an exclusive, worldwide license agreement with RespiVert Ltd.</li><li><a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273160\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$ABIL $NURO $TRNX - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3273160-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3273160-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273159\" data-ts=\"1497359667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AST\" target=\"_blank\">AST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273159-spinal-cord-injury-patients-continue-to-improve-in-asterias-bios-scistar-study-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spinal cord injury patients continue to improve in Asterias Bio&#39;s SCiStar study; shares ahead 8% premarket</a></h4><ul><li>Thinly traded micro cap Asterias Biotherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/AST' title='Asterias Biotherapeutics, Inc.'>AST</a>) perks up&nbsp;<font color='green'>8%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16859953-patients-complete-paralysis-show-additional-recovery-arm-hand-finger-function-9-months\" target=\"_blank\">announcement </a>of new data from ts Phase 1/2a SCiStar study assessing AST-OPC1 in patients with acute spinal cord injury.</li><li>Half of the patients (n=3/6) in the AIS-A 10M-cell cohort have recovered two levels of motor function. Improvements in arm, hand and finger function at months three and six following administration of AST-OPC1 have been confirmed and have improved further at month nine. All six patients have achieved at least one motor level of improvement on at least one side at month nine.</li><li><a href=\"https://clinicaltrials.gov/ct2/show/NCT02302157?term=NCT02302157&amp;rank=1\" target=\"_blank\">SCiStar </a>is evaluating three sequential escalating doses of AST-OPC1 (up to 20M cells) in as many as 35 patients with sub-acute (C-5 to C-7) motor-complete cervical spinal cord injury. The patients have essentially lost all movement below the injury site and have severe paralysis of the upper and lower limbs.</li><li>According the ClinicalTrials.gov, the estimated study completion date is September 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273159\" data-linked=\"Spinal cord injury patients continue to improve in Asterias Bio&#39;s SCiStar study; shares ahead 8% premarket\" data-tweet=\"$AST - Spinal cord injury patients continue to improve in Asterias Bio&#39;s SCiStar study; shares ahead 8% premarket https://seekingalpha.com/news/3273159-spinal-cord-injury-patients-continue-to-improve-in-asterias-bios-scistar-study-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3273159-spinal-cord-injury-patients-continue-to-improve-in-asterias-bios-scistar-study-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273158\" data-ts=\"1497359551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273158-goldman-sachs-takes-profit-on-shopify-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs takes profit on Shopify call</a></h4><ul> <li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) heads lower in early trading after Goldman Sachs lowers it rating to Neutral from Buy after watching the stock double in 2017.</li> <li>The firm deserves credit for its October call of adding Shopify to its Americas Buy List, but can't make the case for \"meaningful upside\" from the current trading level.</li> <li>Source: Bloomberg</li> <li>SHOP <font color='red'>-2.11%</font> premarket to $87.01.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273158\" data-linked=\"Goldman Sachs takes profit on Shopify call\" data-tweet=\"$SHOP - Goldman Sachs takes profit on Shopify call https://seekingalpha.com/news/3273158-goldman-sachs-takes-profit-on-shopify-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3273158-goldman-sachs-takes-profit-on-shopify-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273156\" data-ts=\"1497359415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273156-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273013-science-applications-beats-0_04-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CAKE' title='The Cheesecake Factory Incorporated'>CAKE</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273132-cheesecake-factory-minus-7-percent-guidance-update\" target=\"_blank\">updating</a> Q2 sales guidance.</li><li><a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273156\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SAIC $CAKE $ONCT - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3273156-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3273156-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273145\" data-ts=\"1497358375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273145-mallinckrodt-mulling-strategic-options-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mallinckrodt mulling strategic options; shares ahead 2% premarket</a></h4><ul><li>Wells Fargo's David Maris says Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a>) is exploring all strategic options, including going private. He informed clients in a note after meeting with the company last week.</li><li>Shares have been in a steady downtrend for almost a year. Short seller Citron Research has jumped on the bandwagon saying sales and margins will be under pressure as the price of Acthar gel drops.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on average volume.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3273145\" data-linked=\"Mallinckrodt mulling strategic options; shares ahead 2% premarket\" data-tweet=\"$MNK - Mallinckrodt mulling strategic options; shares ahead 2% premarket https://seekingalpha.com/news/3273145-mallinckrodt-mulling-strategic-options-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3273145-mallinckrodt-mulling-strategic-options-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273136\" data-ts=\"1497357391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FR\" target=\"_blank\">FR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273136-first-industrial-down-1-after-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Industrial down 1% after share sale</a></h4><ul><li>The company sold 2.56M shares in a secondary offering, raising $76M in gross proceeds - suggesting a selling price of about $29.69 each.</li><li><a href='https://seekingalpha.com/symbol/FR' title='First Industrial Realty Trust, Inc.'>FR</a>&nbsp;<font color='red'>-1.1%</font>&nbsp;premarket to $29.72</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273023-capital-raise-first-industrial\" target=\"_blank\">Capital raise from First Industrial</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273136\" data-linked=\"First Industrial down 1% after share sale\" data-tweet=\"$FR - First Industrial down 1% after share sale https://seekingalpha.com/news/3273136-first-industrial-down-1-after-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3273136-first-industrial-down-1-after-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273132\" data-ts=\"1497356827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAKE\" target=\"_blank\">CAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273132-cheesecake-factoryminus-7-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Cheesecake Factory -7% after guidance update</a></h4><ul> <li>The Cheesecake Factory (NASDAQ:<a href='https://seekingalpha.com/symbol/CAKE' title='The Cheesecake Factory Incorporated'>CAKE</a>)&nbsp;refreshes its outlook ahead of two       conference presentations this week.</li><li>The restaurant operator now expects FQ2 comparable       sales to be down approximately 1%.</li>     <li>Company update: \"We have seen heightened volatility in week to week sales       trends, indicative of uncertainty on the part of many consumers.       Specifically, we have seen pockets of softness as we moved through the       quarter, notably in the East and Midwest where we also faced unfavorable       weather that reduced patio usage.\"</li>     <li>Execs are presenting at the William Blair 37<sup>th</sup> Annual       Growth Stock Conference in Chicago today and       the Piper Jaffray 37<sup>th</sup> Annual Consumer Conference in New York       City tomorrow.</li><li>CAKE  <font color='red'>-6.67%</font> premarket to  $54.44.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16859885-cheesecake-factory-updates-second-quarter-fiscal-2017-comparable-sales-outlook\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273132\" data-linked=\"The Cheesecake Factory -7% after guidance update\" data-tweet=\"$CAKE - The Cheesecake Factory -7% after guidance update https://seekingalpha.com/news/3273132-cheesecake-factoryminus-7-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3273132-cheesecake-factoryminus-7-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273127\" data-ts=\"1497356095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273127-goldman-sachs-cools-off-on-mercadolibre\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs cools off on MercadoLibre</a></h4><ul> <li>Shares of MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) are skittish in early trading after Goldman Sachs <a href=\"https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+MercadoLibre+%28MELI%29+to+Neutral/13004817.html\" target=\"_blank\">downgrades</a> the e-commerce stock to Neutral from Buy.</li> <li>GS raises concerns over the near-term cost of MercadoLibre's free shipping campaign.</li><li>The firm lowers its price target to $290 from $309.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3272433-barclays-sees-free-shipping-boost-mercadolibre\" target=\"_blank\">Barclays sees free shipping boost for MercadoLibre</a> (June 8)</li><li>Shares of MELI are&nbsp;<font color='red'>down 2.26%</font>&nbsp;to $264.60 in premarket action.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273127\" data-linked=\"Goldman Sachs cools off on MercadoLibre\" data-tweet=\"$MELI - Goldman Sachs cools off on MercadoLibre https://seekingalpha.com/news/3273127-goldman-sachs-cools-off-on-mercadolibre?source=tweet\" data-url=\"https://seekingalpha.com/news/3273127-goldman-sachs-cools-off-on-mercadolibre\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273116\" data-ts=\"1497355429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273116-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) initiated with Buy rating and $85 (42% upside) price target by Leerink. Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket on light volume.</li><li>SCYNEXIS (NASDAQ:<a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a>) initiated with Buy rating by National Securities.</li><li>Alkermes (NASDAQ:<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a>) downgraded to Market Perform with $61 price target by Leerink.Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li><li>Athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) downgraded to Neutral by Cantor Fitzgerald.</li><li>Acceleron Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) downgraded to Market Perform by Oppenheimer. Shares are down&nbsp;<font color='red'>8%</font>&nbsp;premarket on light volume.</li><li>Zoetis (NYSE:<a href='https://seekingalpha.com/symbol/ZTS' title='Zoetis'>ZTS</a>) downgraded to Market Perform by BMO.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3273116\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CLVS $CLVS $SCYX - Premarket analyst action - healthcare https://seekingalpha.com/news/3273116-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3273116-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273109\" data-ts=\"1497354249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273109-berenberg-raves-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Berenberg raves about Tesla</a></h4><ul> <li>Germany-based Berenberg <a href=\"https://www.streetinsider.com/Analyst+Comments/Berenberg+Upgrades+Tesla+Motors+%28TSLA%29+to+Buy/13004896.html\" target=\"_blank\">upgrades</a> Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) to a Buy rating on its view that the company won't face mass-market EV competition from traditional manufacturers.</li> <li>Analyst Alexander Haissl calls near-term results \"unimportant\" as the company works its way to \"superior\" free cash flow realization in the long term.</li> <li>\"Tesla's disruptive potential encompasses the vehicle, the entire production process and the product-to-market strategy. Once the business reaches scale, the cash generation potential is significantly superior to existing premium OEMs, with cash flow per vehicle more than 50% higher,\" writes Haissl.</li><li>Berenberg lifts its price target on Tesla to $464.</li><li>TSLA <font color='green'>+2.33%</font> premarket to $367.40.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273109\" data-linked=\"Berenberg raves about Tesla\" data-tweet=\"$TSLA - Berenberg raves about Tesla https://seekingalpha.com/news/3273109-berenberg-raves-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3273109-berenberg-raves-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>224&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273107\" data-ts=\"1497353950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NURO\" target=\"_blank\">NURO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273107-neurometrix-awarded-new-u-s-patent-covering-quell-pain-relief-device-shares-ahead-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeuroMetrix awarded new U.S. patent covering Quell pain relief device; shares ahead 5% premarket</a></h4><ul><li>Thinly traded nano cap NeuroMetrix (NASDAQ:<a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a>) is up&nbsp;<font color='green'>5%&nbsp;</font>premarket, albeit on only 860 shares, in response to its <a href=\"https://seekingalpha.com/pr/16859750-neurometrix-announces-issuance-new-u-s-patent-quell-wearable-pain-relief-technology\" target=\"_blank\">announcement </a>that the USPTO has issued U.S. Patent No. 9,675,801 covering novel mechanisms to help Quell users safely obtain pain relief therapy over extended periods of time. The patent covers claims for technology to monitor the amount of time Quell is worn and to provide notifications to the user.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273107\" data-linked=\"NeuroMetrix awarded new U.S. patent covering Quell pain relief device; shares ahead 5% premarket\" data-tweet=\"$NURO - NeuroMetrix awarded new U.S. patent covering Quell pain relief device; shares ahead 5% premarket https://seekingalpha.com/news/3273107-neurometrix-awarded-new-u-s-patent-covering-quell-pain-relief-device-shares-ahead-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3273107-neurometrix-awarded-new-u-s-patent-covering-quell-pain-relief-device-shares-ahead-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273105\" data-ts=\"1497353709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273105-model-x-aces-nhtsa-crash-tests\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Model X aces NHTSA crash tests</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) says the Model X is the first SUV to achieve a 5-star crash rating in every category through testing by the National Highway Traffic Safety Administration.</li> <li>Tesla on safety: \"Model X performs so much better in a crash than gas-powered SUVs because of its all-electric architecture and powertrain design. The rigid, fortified battery pack that powers Model X is mounted beneath the floor of the vehicle creating a center of gravity so low that Model X has the lowest rollover probability of any SUV on the road,\"</li> <li><a href=\"https://www.tesla.com/blog/tesla-model-x-5-star-safety-rating\" target=\"_blank\">Tesla blog post</a></li> <li>Shares of Tesla are <font color='green'>up 2.09%</font> premarket to $366.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273105\" data-linked=\"Model X aces NHTSA crash tests\" data-tweet=\"$TSLA - Model X aces NHTSA crash tests https://seekingalpha.com/news/3273105-model-x-aces-nhtsa-crash-tests?source=tweet\" data-url=\"https://seekingalpha.com/news/3273105-model-x-aces-nhtsa-crash-tests\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>111&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273099\" data-ts=\"1497353122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273099-second-late-stage-uveitis-study-of-psividas-durasert-successful-shares-ahead-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Second late-stage uveitis study of pSivida&#39;s Durasert successful; shares ahead 13% premarket</a></h4><ul><li>Nano cap pSivida (PSDV) is up&nbsp;<font color='green'>13%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16859795-psivida-s-durasert-three-year-treatment-posterior-segment-uveitis-successfully-achieves\" target=\"_blank\">announcement </a>of positive results in a second Phase 3 clinical trial assessing Durasert for the treatment of posterior segment uveitis &#40;PSU&#41;.</li><li>Results at month six showed patients receiving Durasert experienced a 21.8% recurrence of PSU compared to 53.8% in patients receiving a sham insert (placebo) (p&lt;0.001).</li><li>On the safety front, patients in the Durasert cohort experienced higher elevations in intraocular pressure &#40;IOP&#41;&nbsp;than the sham group (2.4 mmHg vs. 1.3 mmHg, respectively, compared to baseline). 41.6% of the Durasert cohort required IOP-lowering therapy at some time during the first six months compared to 34.6% in the sham cohort.</li><li><a href=\"http://www.psivida.com/our-technology/#durasert\" target=\"_blank\">Durasert </a>is a miniaturized injectable sustained-release drug delivery system for small molecules (up to three years). The implant can be administered in an office setting via a needle as small as 25-gauge.</li><li>Management will host a conference call today at 4:30 pm ET to discuss the data.</li><li><strong>Update</strong>: The stock experienced abnormal volatility in early trading, with a high/low range of $2.30/1.73.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>13%</font>&nbsp;on the IOP effect since PSU can lead to glaucoma.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273099\" data-linked=\"Second late-stage uveitis study of pSivida&#39;s Durasert successful; shares ahead 13% premarket\" data-tweet=\"$EYPT - Second late-stage uveitis study of pSivida&#39;s Durasert successful; shares ahead 13% premarket https://seekingalpha.com/news/3273099-second-late-stage-uveitis-study-of-psividas-durasert-successful-shares-ahead-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3273099-second-late-stage-uveitis-study-of-psividas-durasert-successful-shares-ahead-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":58,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}